Notice_of_Intent_Sole_Source.pdf

The US Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, Maryland intends to negotiate on a sole source basis with Siemens Healthcare Diagnostics Inc., Glasgow Business Community, PO Box 6101, Newark, DE 19714- 6101as the only responsible source capable of meeting the following MEC’s:

Siemens Dimension EXL 200 Integrated Chemistry System

1. Shall have technologies in one system:

• advanced chemiluminescence

• Heterogeneous Module

• Photometry

• User-defined serum index (HIL) testing

• Automation capabilities

2. Shall have a comprehensive testing menu to support multiple research protocols, including: cardiovascular, toxicology, general chemistry, specific proteins, and therapeutic drug monitoring, to include: alanine aminotransferase, albumin, alkaline phosphatase, amylase, bilirubin, calcium, carbon dioxide, chloride, cholesterol, creatine, creatine kinase- MB,creatinine, gamma-glutamyl transferase, glucose, immunoglobulins A, G, and M, lactate dehydrogenase, lactic acid, lipase, magnesium, myoglobin, phosphorus, potassium, sodium, tobramycin, total protein, triglyceride, troponin, urea nitrogen, uric acid, and vancomycin.

3. Shall have chemiluminescence technology for reliable results with high sensitivity with low sample volume required.

4. Shall have general chemistry and immunoassay integration technology to allow simultaneous processing to maximize workflow efficiency in one single test system.

5. Shall perform testing on different sample types: serum, plasma, urine and other body fluids to support multiple research protocols.

6. Shall able to perform automatic repeat testing from the original sample.

7. Shall able to perform automatic dilution: 1:15 to 1:200

8. Shall have liquid-level sensing, clot detection, short-sample detection

9. Shall have automated wash to prevent sample carryover prevention

10. Shall have bar-code reagent identification; automatic inventory tracking and flagging; calibration and control validity tracking and flagging; reagent onboard tracking of tests remaining, lot number, onboard stability, and expiration date.

There are no set-aside restrictions for this requirement. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Kasey Carroll at kasey.l.carroll.civ@mail.mil. Closing date for challenges is no later than 11:00 AM ET on 25 February 2016. No phone calls will be accepted.

mailto:kasey.l.carroll.civ@mail.mil